Stockreport

Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. With the [Read more]